The Antitumor Effects of α-Linolenic Acid.

anticancer drugs polyunsaturated fatty acid tumor biology α-linolenic acid

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
28 Feb 2024
Historique:
received: 29 01 2024
revised: 23 02 2024
accepted: 26 02 2024
medline: 28 3 2024
pubmed: 28 3 2024
entrez: 28 3 2024
Statut: epublish

Résumé

α-linolenic acid (ALA), which is a member of the n-3 polyunsaturated fatty acid (n-3 PUFA) family, has often been ignored due to a lack of information. ALA has gradually attracted increased attention due to its nutritional and medicinal advantages. Studies have shown that ALA exerts beneficial effects on a variety of diseases, including cancer. In this review, we summarize the antitumor effects of ALA in the context of cell biology, including the inhibition of proliferation, the induction of apoptosis, the inhibition of metastasis and angiogenesis, and antioxidant effects. In addition, studies have shown that ALA can be used as a drug carrier or exert positive clinical effects when combined with drugs. Therefore, the use of ALA in clinical treatments is very promising and valuable.

Identifiants

pubmed: 38541002
pii: jpm14030260
doi: 10.3390/jpm14030260
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : National Natural Science Foundation of China
ID : 82272981

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Auteurs

Huirong Yan (H)

Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Department of Medical Microbiology, School of Basic Medical Science, Central South University, Changsha 410078, China.

Senmiao Zhang (S)

Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Department of Medical Microbiology, School of Basic Medical Science, Central South University, Changsha 410078, China.

Li Yang (L)

Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Department of Medical Microbiology, School of Basic Medical Science, Central South University, Changsha 410078, China.

Mingjuan Jiang (M)

Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Department of Medical Microbiology, School of Basic Medical Science, Central South University, Changsha 410078, China.

Yujie Xin (Y)

Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Department of Medical Microbiology, School of Basic Medical Science, Central South University, Changsha 410078, China.

Xuefei Liao (X)

Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
Department of Medical Microbiology, School of Basic Medical Science, Central South University, Changsha 410078, China.

Yanling Li (Y)

Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.

Jianhong Lu (J)

Department of Medical Microbiology, School of Basic Medical Science, Central South University, Changsha 410078, China.

Classifications MeSH